Cumberland Pharmaceuticals Inc (NAS:CPIX)
$ 1.28 0.03 (2.4%) Market Cap: 18.04 Mil Enterprise Value: 21.85 Mil PE Ratio: 0 PB Ratio: 0.68 GF Score: 51/100

Q3 2020 Cumberland Pharmaceuticals Inc Earnings Call Transcript

Nov 10, 2020 / 09:30PM GMT
Release Date Price: $3.05 (+2.01%)
Operator

Thank you for joining the Cumberland Pharmaceuticals Third Quarter 2020 Financial Report and Company Update. Please note that this conference call is being recorded at the company's request and will be archived on Cumberland's website for one week from today's date.

Now I would like to introduce Erin Gull, who handles Corporate Relations at Cumberland. Erin, please go ahead.

Erin Smith Gull
Cumberland Pharmaceuticals Inc. - Senior Corporate Relations Associate

Good afternoon, everyone. Earlier today, we issued a press release containing the company's financial results for the third quarter ended September 30, 2020. You can find a copy of that release on our website at www.cumberlandpharma.com. Please note that today's discussion may include forward-looking statements as defined in the Private Securities Reform Act of 1995. And because any such statements reflect the company's current views and expectations concerning future events, they may involve risks and uncertainties.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot